STOCK TITAN

Director Steven Collis adds BLCO stake with 15,000-share buy and RSU grant

Filing Impact
(Moderate)
Filing Sentiment
(Positive)
Form Type
4

Rhea-AI Filing Summary

Bausch & Lomb director Steven H. Collis reported two transactions in common shares. He made an open-market purchase of 15,000 shares at a weighted average price of $17.81 per share, increasing his direct holdings. He also received 4,491 matching restricted share units (MRSUs) granted under the company’s matching share program, tied to this purchase. One-third of these MRSUs will vest on each of the first, second, and third anniversaries of the grant, subject to his continued service. Following these transactions, he directly owned 24,746 common shares.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
COLLIS STEVEN H

(Last) (First) (Middle)
C/O BAUSCH + LOMB CORPORATION
520 APPLEWOOD CRESCENT

(Street)
VAUGHN A6 L4K 4B4

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Bausch & Lomb Corp [ BLCO ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
02/23/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Shares, No Par Value 02/23/2026 P 15,000 A $17.81(1) 20,255 D
Common Shares, No Par Value 02/23/2026 A 4,491(2) A $0 24,746 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Reflects a weighted average price. These shares were purchased in multiple transactions at prices ranging from $17.77 to $17.85 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
2. Represents matching restricted share units ("MRSUs") granted to the reporting person in connection with the open market purchase of common shares reported on Table I above, pursuant to the issuer's matching share program. One-third of the MRSUs will vest on each of the first, second, and third anniversaries following the date of grant, subject to the reporting person's continued service (except in limited circumstances).
/s/ Debra E. Levin, attorney-in-fact 02/24/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Bausch & Lomb (BLCO) director Steven H. Collis report?

Steven H. Collis reported an open-market purchase of 15,000 Bausch & Lomb common shares and an award of 4,491 matching restricted share units. Both transactions increased his direct ownership stake in the company’s common equity as of the reported date.

At what price did Steven H. Collis buy Bausch & Lomb (BLCO) shares?

He purchased 15,000 common shares at a weighted average price of $17.81 per share. The filing notes individual trades occurred between $17.77 and $17.85, and detailed breakdowns are available on request from the issuer or regulatory staff.

What are the 4,491 matching restricted share units reported for Bausch & Lomb (BLCO)?

The 4,491 matching restricted share units are MRSUs granted in connection with Collis’s open-market share purchase under the company’s matching share program. These units represent contingent share rights that vest over time rather than immediate freely tradable shares.

How do the MRSUs granted to Steven H. Collis in BLCO vest?

The matching restricted share units vest in three equal installments. One-third vests on each of the first, second, and third anniversaries of the grant date, contingent on Collis’s continued service, except in certain limited circumstances described by the company.

How many Bausch & Lomb (BLCO) shares does Steven H. Collis own after these Form 4 transactions?

After the reported purchase and award, Collis directly owned 24,746 Bausch & Lomb common shares. This figure reflects his direct ownership position immediately following the Form 4 transactions and does not separately list future vesting of restricted share units.

What type of transaction code was used for Steven H. Collis’s BLCO share purchase?

The open-market purchase of 15,000 shares used transaction code “P,” indicating a purchase in the open market or a private transaction. The grant of 4,491 matching restricted share units used transaction code “A,” signifying a grant, award, or other acquisition.
Bausch + Lomb Corporation

NYSE:BLCO

BLCO Rankings

BLCO Latest News

BLCO Latest SEC Filings

BLCO Stock Data

6.37B
38.57M
Medical Instruments & Supplies
Ophthalmic Goods
Link
Canada
VAUGHAN